Cargando…

Serial Urinary C-C Motif Chemokine Ligand 14 and Risk of Persistent Severe Acute Kidney Injury

To assess the added prognostic value of serial monitoring of urinary C-C motif chemokine ligand 14 (uCCL14) over that of single measurements, which have been shown to be prognostic for development of persistent severe acute kidney injury (AKI) in critically ill patients. DESIGN: Retrospective observ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prowle, John R., Artigas, Antonio, Bagshaw, Sean M., Forni, Lui G., Heung, Michael, Hoste, Eric, Marlies, Ostermann, Koyner, Jay L., Chawla, Lakmir, Kampf, J. Patrick, Kwan, Thomas, McPherson, Paul, Kellum, John A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Original Clinical Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981369/ https://www.ncbi.nlm.nih.gov/pubmed/36875557 http://dx.doi.org/10.1097/CCE.0000000000000870

Ejemplares similares

External validation of urinary C–C motif chemokine ligand 14 (CCL14) for prediction of persistent acute kidney injury
por: Bagshaw, Sean M., et al.
Publicado: (2021)

Predicting the Development of Renal Replacement Therapy Indications by Combining the Furosemide Stress Test and Chemokine (C-C Motif) Ligand 14 in a Cohort of Postsurgical Patients
por: Meersch, Melanie, et al.
Publicado: (2023)

Identification and validation of biomarkers of persistent acute kidney injury: the RUBY study
por: Hoste, Eric, et al.
Publicado: (2020)

What every Intensivist should know about COVID-19 associated acute kidney injury
por: Ostermann, Marlies, et al.
Publicado: (2020)

Kinetics of Urinary Cell Cycle Arrest Markers for Acute Kidney Injury Following Exposure to Potential Renal Insults
por: Ostermann, Marlies, et al.
Publicado: (2018)

Use of Cell Cycle Arrest Biomarkers in Conjunction With Classical Markers of Acute Kidney Injury
por: Joannidis, Michael, et al.
Publicado: (2019)

Serial Urinary C-C Motif Chemokine Ligand 14 and Risk of Persistent Severe Acute Kidney Injury: Erratum
Publicado: (2023)

Broad spectrum vasopressors: a new approach to the initial management of septic shock?
por: Chawla, Lakhmir S., et al.
Publicado: (2019)

Measuring biomarkers of acute kidney injury during renal replacement therapy: wisdom or folly?
por: Ostermann, Marlies, et al.
Publicado: (2014)

Urine TIMP2 × IGFBP7 increases 24 hours before severe AKI
por: Ostermann, M, et al.
Publicado: (2014)

Lung–kidney interactions in critically ill patients: consensus report of the Acute Disease Quality Initiative (ADQI) 21 Workgroup
por: Joannidis, Michael, et al.
Publicado: (2019)

Cytotoxic chemotherapy reduces T cell trafficking to the spleen by downregulating the expression of C-C motif chemokine ligand 21 and C-C motif chemokine ligand 19
por: Liu, Lina, et al.
Publicado: (2018)

Long-term sequelae from acute kidney injury: potential mechanisms for the observed poor renal outcomes
por: Varrier, Matt, et al.
Publicado: (2015)

Acute kidney injury in the critically ill: an updated review on pathophysiology and management
por: Pickkers, Peter, et al.
Publicado: (2021)

Potentials of C‐C motif chemokine 2–C‐C chemokine receptor type 2 blockers including propagermanium as anticancer agents
por: Yumimoto, Kanae, et al.
Publicado: (2019)

Chemokine (C-X-C motif) ligand 1/chemokine (C-X-C motif) receptor 2 autocrine loop contributes to cellular proliferation, migration and apoptosis in cervical cancer
por: Sun, Jiping, et al.
Publicado: (2022)

Plasma levels of monokine induced by interferon-gamma/chemokine (C-X-X motif) ligand 9, thymus and activation-regulated chemokine/chemokine (C-C motif) ligand 17 in children with Kawasaki disease
por: Feng, Siqi, et al.
Publicado: (2015)

The Significance of Selected C-C Motif Chemokine Ligands in Colorectal Cancer Patients
por: Zajkowska, Monika, et al.
Publicado: (2022)

Performance of urinary C–C motif chemokine ligand 14 for the prediction of persistent acute kidney injury: a systematic review and meta-analysis
por: Chen, Yih‑Ting, et al.
Publicado: (2023)

Clinical review: Biomarkers of acute kidney injury: where are we now?
por: Ostermann, Marlies, et al.
Publicado: (2012)

Goal-directed therapy and acute kidney injury: as good as it gets?
por: Doyle, James F., et al.
Publicado: (2016)

Combination of C-X-C motif chemokine 9 and C-X-C motif chemokine 10 antibodies with FTY720 prolongs the survival of cardiac retransplantation allografts in a mouse model
por: MA, TENG, et al.
Publicado: (2015)

Quality of Care for Acute Kidney Disease: Current Knowledge Gaps and Future Directions
por: Liu, Kathleen D., et al.
Publicado: (2020)

Diverse activation of microglia by chemokine (C-C motif) ligand 2 overexpression in brain
por: Selenica, Maj-Linda B, et al.
Publicado: (2013)

Role of chemokine C-C motif ligand-1 in acute and chronic pulmonary inflammations
por: Kishi, Hiroyuki, et al.
Publicado: (2016)

Expression of C–C motif chemokines and their receptors in bovine placentomes at spontaneous and induced parturition
por: HIRAYAMA, Hiroki, et al.
Publicado: (2019)

Vascular Stem/Progenitor Cell Migration Induced by Smooth Muscle Cell‐Derived Chemokine (C‐C Motif) Ligand 2 and Chemokine (C‐X‐C motif) Ligand 1 Contributes to Neointima Formation
por: Yu, Baoqi, et al.
Publicado: (2016)

Ethanol promoting the upregulation of C-X-C Motif Chemokine Ligand 1（CXCL1） and C-X-C Motif Chemokine Ligand 6（CXCL6） in models of early alcoholic liver disease
por: Jiang, Yao, et al.
Publicado: (2022)

Impacts of Chemokine (C-X-C Motif) Receptor 2 C1208T Polymorphism on Cancer Susceptibility
por: Zhou, Jing, et al.
Publicado: (2021)

Elevated signal transducers and activators of transcription 1 correlates with increased C-C motif chemokine ligand 2 and C-X-C motif chemokine 10 levels in peripheral blood of patients with systemic lupus erythematosus
por: Dominguez-Gutierrez, Paul R, et al.
Publicado: (2014)

Fluid overload and acute kidney injury: cause or consequence?
por: Ostermann, Marlies, et al.
Publicado: (2015)

Common chronic conditions do not affect performance of cell cycle arrest biomarkers for risk stratification of acute kidney injury
por: Heung, Michael, et al.
Publicado: (2016)

Reduced expression of chemokine (C-C motif) ligand-2 (CCL2) in ovarian adenocarcinoma
por: Arnold, J M, et al.
Publicado: (2005)

The Effect of C-X-C Motif Chemokine 13 on Hepatocellular Carcinoma Associates with Wnt Signaling
por: Li, Chunyan, et al.
Publicado: (2015)

The Critical Role of Chemokine (C–C Motif) Receptor 2-Positive Monocytes in Autoimmune Cholangitis
por: Reuveni, Debby, et al.
Publicado: (2018)

Chemokine C-C Motif Ligand 4 Gene Polymorphisms Associated with Susceptibility to Rheumatoid Arthritis
por: Kuo, Shu-Jui, et al.
Publicado: (2018)

Role of Chemokine (C–X–C Motif) Ligand 10 (CXCL10) in Renal Diseases
por: Gao, Jie, et al.
Publicado: (2020)

Chemokine (C-C Motif) Ligand 8 and Tubulo-Interstitial Injury in Chronic Kidney Disease
por: Lee, Jangwook, et al.
Publicado: (2022)

Plasma Chemokine C-C Motif Ligand 2 as a Potential Biomarker for Prostate Cancer
por: Lund, Martin, et al.
Publicado: (2022)

Multifaceted Roles of Chemokine C-X-C Motif Ligand 7 in Inflammatory Diseases and Cancer
por: Wu, Qianmiao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_me32j011ep71cvirbl3b25ci8k